Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A promising clinical treatment for EGFRI-induced rash by targeting the early pathological alteration revealed by transcriptome analysis

ABSTRACT: A promising clinical treatment for EGFRI-induced rash by targeting the early pathological alteration revealed by transcriptome analysis

PROVIDER: PRJNA831901 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR18918022_1.fastq.gz	Fastqsanger.gz
	SRR18918022_2.fastq.gz	Fastqsanger.gz
	SRR18918023_1.fastq.gz	Fastqsanger.gz
	SRR18918023_2.fastq.gz	Fastqsanger.gz
	SRR18918024_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 30

Similar Datasets

A promising clinical treatment for EGFRI-induced rash by targeting the early pathological alteration revealed by transcriptome analysis

Project description:In order to investigate the early pathological alteration of EGFRI-induced rash, we treated rat with vehicle or afatinib for 3 days. We then performed gene expression profiling analysis using data obtained from RNA-Seq of 3 different rat skins in each group

2024-05-20 | GSE201504 | GEO

Genetic, clinical, and biomarker correlates of EGFR inhibitor-related rash

Project description:Genetic, clinical, and biomarker correlates of EGFR inhibitor-related rash

| PRJNA475113 | ENA

Vitamin D3 and deconvoluting a rash

Project description:Vitamin D3 and deconvoluting a rash

| PRJNA905668 | ENA

Sequencing and Quantitative Analysis of Skin Transcriptomes from Rats with EGFR Inhibitors Induced Rash

Project description:Skin mRNA profiles of wild-type (WT) and EGFR Inhibitors (Gefitinib and Afatinib) induced rash rats were generated by deep sequencing, in triplicate, using Illumina GAIIx. Raw sequences were mapped to the rat reference sequence by Hisat2 v2.0.5. FeatureCounts v1.5.0-p3 was used to count the reads numbers mapped to each gene. FPKM of each gene was calculated based on the length of the gene and reads count mapped to this gene. Differential expression analysis was performed using the DESeq2 R package (1.16.1).

2022-04-04 | GSE199970 | GEO

AnxA1 inhibits pathological bone resorption

Project description:AnxA1 inhibits pathological bone resorption

| PRJNA759264 | ENA

Single-cell RNA sequencing analysis of a COVID-19– associated maculopapular rash in a patient with psoriasis treated with ustekinumab

Project description:Coronavirus disease 2019 (COVID-19) primarily affects the respiratory system but extrapulmonary manifestations, including the skin, have been well documented. However, transcriptomic profiles of skin lesions have not been performed thus far. Here, we present a single-cell RNA sequencing analysis in a patient with COVID-19 infection with a maculopapular skin rash while on treatment with the interleukin (IL)-12/IL-23 blocker ustekinumab for underlying psoriasis. Results were compared with healthy controls and untreated psoriasis. We found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral entry receptors ACE2 and TMPRSS2 in keratinocytes of the patient with COVID-19, while ACE2 expression was low to undetectable in psoriasis lesions and healthy skin. Among all cell types, ACE2+ keratinocyte clusters showed the highest levels of transcriptomic dysregulation in COVID-19, expressing type 1–associated immune markers such as CXCL9 and CXCL10. In line with a generally type 1–skewed immune microenvironment, cytotoxic lymphocytes showed increased expression of the IFNG gene and other T-cell effector genes, while type 2, type 17, or type 22 T-cell activation was largely absent. Conversely, downregulation of several anti-inflammatory mediators was observed. This first transcriptomic description of a COVID-19-associated rash identifies ACE2+ keratinocytes displaying profound transcriptional changes, and inflammatory immune cells that might help to improve the understanding of SARS-CoV-2-associated skin conditions.

2023-03-27 | GSE206147 | GEO

Molecular Pathological Epidemiology of Colorectal Cancer

Project description:Molecular Pathological Epidemiology of Colorectal Cancer

| PRJNA640199 | ENA

Molecular Pathological Epidemiology of Colorectal Cancer

Project description:Molecular Pathological Epidemiology of Colorectal Cancer

| PRJNA640198 | ENA

Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients

Project description:The purpose of this study is to determine if using preventive treatments such as Doxycycline (an anti-biotic) capsules, sunscreen with SPF 30, Hydrocortisone 1% cream and a moisturizer will help to reduce the incidence and severity of the skin rash associated with Cetuximab (Erbitux) when compared to receiving standard care for the treatment of skin rash.

| 2146434 | ecrin-mdr-crc

Microbiota alteration upon blueberry consumption

Project description:Microbiota alteration upon blueberry consumption

| PRJNA679320 | ENA